European defibrillators market is expected to grow significantly owing to the Sudden Cardiac Death(SCD) and is responsible for about 20% of total mortalities in Europe. Sudden cardiac death claims for more than 350,000 lives per year in Europe. This disease is the predominant risk of death for patients with heart failure. The disease is deadly within minutes if left untreated and its survival rate is just 5%-20%. It is considered as a significant economic burden on a societal basis. Additionally, it is estimated to cost between $860,000 and $1.6 million per case. Moreover, the risk increases for patients suffering from a myocardial infarction. Such high prevalence and mortalities due to cardiac arrest are considered as the most important factors in the defibrillator's market growth
European network has been created in the region to find sudden cardiac arrest causes and compare treatments. This network, formerly known as the European Sudden Cardiac Arrest network (ESCAPE-NET), is backed by the ERC and European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC). Additionally, it is being funded by a European Union Horizon 2020 grant. 16 scientific teams in ESCAPE-NET across Europe are pooling their expertise and patient populations for creating a database of SCA suffering by the community's population and it is sufficiently large to study causes, treatments, and prevention strategies. This database includes more than 80,000 SCA patients with around 20,000 DNA samples.
Further, several European policies and regulations are meant to safeguard patients and ensure the safety and security of the citizens and keenly observe medical devices and services. Stringent regulations and policies enable to avoid entry of drugs and devices that might be a risk to patients on using medical devices and services, which contributes to the significant growth of the defibrillator market.
The market study of the European Defibrillators market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
1. European Defibrillators Market Research and Analysis by Type
2. European Defibrillators Market Research and Analysis by End-users
The Report Covers
- Comprehensive research methodology of the European Defibrillators market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the European Defibrillators market.
- Insights about market determinants which are stimulating the European Defibrillators market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
5. Market Segmentation
5.1. European Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. European Defibrillators Market by End-Users
5.2.2. Ambulatory Services and Others
6. Regional Analysis
6.6. Rest of Europe
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Biotronik SE & Co. KG
7.3. Cintas Corp.
7.4. Defibtech, LLC
7.5. General Electric Co.
7.6. Koninklijke Philips N.V.
7.7. LivaNova PLC
7.8. Medtronic PLC
7.9. Mindray Medical International Co. Ltd.
7.10. Nihon Kohden Corp.
7.11. Stryker Corp
- Abbott Laboratories, Inc.
- Biotronik SE & Co. KG
- Cintas Corp.
- Defibtech, LLC
- General Electric Co.
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic PLC
- Mindray Medical International Co. Ltd.
- Nihon Kohden Corp.
- Stryker Corp.